Miconazole: Difference between revisions
(Creation of page) |
ClaireLewis (talk | contribs) No edit summary |
||
| Line 70: | Line 70: | ||
<references/> | <references/> | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] [[Category:ID]] | ||
Revision as of 23:27, 22 September 2019
Administration
- Type: Antifungal
- Dosage Forms: 2% Cream
- Routes of Administration: Topical
- Common Trade Names: Monistat-Derm, Desenex, Lotrimin, Micatin, Zeasorb
Adult Dosing
Candidiasis, cutaneous
- Apply 2% Cream BID to affected area x2 weeks
Tinea corporis
- Apply 2% Cream BID to affected area x4 weeks
Tinea cruris
- Apply 2% Cream BID to affected area x2 weeks
Tinea pedis
- Apply 2% Cream BID to affected area x4 weeks
Pediatric Dosing
Candidiasis, cutaneous
- Apply 2% Cream BID to affected area x2 weeks
Tinea corporis
- Apply 2% Cream BID to affected area x4 weeks
Tinea cruris
- Apply 2% Cream BID to affected area x2 weeks
Tinea pedis
- Apply 2% Cream BID to affected area x4 weeks
Special Populations
Pregnancy Rating
- Risk of fetal harm no expected
- May use during pregnancy
Lactation risk
- May use while breastfeeding
Renal Dosing
- Adult: Not defined
- Pediatric: Not defined
Hepatic Dosing
- Adult: Not defined
- Pediatric: Not defined
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- May occur, but none reported
Common
- Irritation, burning, stining
- Pruritus, erythema, maceration
- Contact dermatitis
Pharmacology
- Half-life: Unknown
- Metabolism: None, minimal systemic absorption
- Excretion: None
Mechanism of Action
- Inhibits 14-alpha demethylase, reducing fungal cell membrane ergosterol synthesis
